Pegfilgrastim biosimilar (Dong-A ST)

聚乙二醇化非格司亭生物类似药 (Dong-A ST)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Dong-A ST)
Drug Alias NamePEG-filgrastim (Dong-A ST)聚乙二醇化非格司亭生物仿制药 (Dong-A ST)聚乙二醇培非拉司亭生物仿制药 (Dong-A ST)Tripegfilgrastim聚乙二醇培非格司亭生物仿制药 (Dong-A ST) +[10] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2014/01/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A Pharmaceutical Co Ltd
Inactive CompaniesDong-A ST Co Ltd
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A